FDA's Role in the Silicone Breast Implant Story

DSpace/Manakin Repository

. . . . . .

Title:	FDA's Role in the Silicone Breast Implant Story
Author:	Friedland, Shelly
Citation:	FDA's Role in the Silicone Breast Implant Story (1997 Third Year Paper)
Full Text & Related Files:	sfriedla.pdf (240.2Kb; PDF) sfriedla.rtf (124.4Kb; RTF file) sfriedla.html (86.82Kb; HTML)
Abstract:	This paper will present the history of FDA's policy regarding silicone breast implants, as well as an analysis of the strengths and weaknesses of these actions. Although FDA Commissioner David Kessler's essential judgment that the implants had not been proven safe was sound, both in evaluating the nature and quality of the scientific evidence available, and in adhering to the Congressional guidelines for the type of proof necessary before a device can be approved for marketing, there were many flaws along the way.
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846748